Fatigue in patients with cancer receiving interferon alpha

Area of Science:

• Oncology
• Symptom Management
• Patient Experience Research

Background:

• Fatigue is a prevalent symptom in cancer patients.
• Interferon alpha is a common cancer treatment associated with significant side effects.
• Understanding fatigue dynamics is crucial for improving patient care and quality of life.

Purpose of the Study:

• To describe the experience of fatigue over time in cancer patients receiving interferon alpha.
• To explore patients' perceptions of fatigue causes and remedies during treatment.
• To apply Piper's Integrated Fatigue Model to analyze fatigue patterns.

Main Methods:

• Descriptive repeated-measures design.
• Convenience sample of 30 malignant melanoma patients.
• Data collected using the Symptom Distress Scale and Piper Fatigue Scale at five time points.

Main Results:

• Consistent patterns of fatigue were observed across five treatment time points.
• The affective and sensory domains exhibited the most extreme fatigue scores.
• Fatigue severity and temporal aspects were also significant dimensions of the experience.

Conclusions:

• The study provides descriptive data on fatigue experienced by patients on interferon alpha.
• Findings have implications for the care of cancer patients receiving interferon alpha therapy.
• Further research into fatigue as a critical aspect of quality of life is warranted.